ERAS
Erasca, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 4 ▼ 1 insider sell $300.8K at $15.04
- Apr 1 ▼ 1 insider sell $1.3M at $16.40
- Apr 27 ▲ Erasca reported highly positive preliminary Phase 1 data for pan-RAS…
- Jun 4 ▲ B of A Securities upgrades
- Jun 12 ▲ 17 institutions accumulated $24.5M in Erasca (ERAS) during 2024-Q3 (…
- Jul 13 ▲ Erasca reported encouraging preliminary Phase 1 data for ERAS-0015,…
- Jul 14 Erasca priced an upsized public offering of 31,428,572 shares at $17…
- Jul 14 Erasca is conducting a $550M follow-on offering of 31.4M shares at $…
- Jul 14 ▼ Erasca has priced an upsized public offering of 31,428,572 shares at…
- Aug 13 ▲ A strong institutional cluster formed in ERAS during 2026-Q2, with 1…
- Sep 16 Trial readout: Results Pending: ERAS-007 (Phase 2), Completed 77d ago
- Sep 30 ▲ 3 funds open new positions (13F)
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders sold $1.6M.
- InstitutionsBULLISH
Q3 2026: 36 added (3 new), 18 trimmed or exited. Largest new: Qube Research & Technologies $18.4M.
- EstimatesFALLING
Current-quarter EPS estimate −$0.126 → −$0.152 over 90 days. 4 up, 4 down in 30 days.
- Short sellersSTEADY
Short interest +0.5% to 37.16M shares. 8.9 days to cover, ≈10.6% of shares.
- TrendUPTREND
1% above its 50-day average.
- SocialQUIET
Crowd 60° (warm) this week from 1 mention: 1 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Capital World Investors | DOUBLED | $137.2M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | DOUBLED | $123.9M |
| Assenagon Asset Management S.A. | DOUBLED | $60.5M |
| UBS Group AG | ADD | $40.1M |
| FEDERATED HERMES, INC. | ADD | $23.0M |
| Qube Research & Technologies Ltd | NEW | $18.4M |
| JPMORGAN CHASE & CO | DOUBLED | $16.1M |
| Rafferty Asset Management, LLC | ADD | $5.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Aug 2026Price is below the lowest target. Median implies +46%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 14, 2026 | B of A Securities MAINTAIN | Neutral |
| Aug 13, 2026 | Guggenheim MAINTAIN | Buy |
| Aug 12, 2026 | HC Wainwright & Co. MAINTAIN | Buy |
| Jul 20, 2026 | Morgan Stanley MAINTAIN | Equal-Weight |
| Jul 14, 2026 | B of A Securities MAINTAIN | Neutral |
| Jun 4, 2026 | B of A Securities UPGRADE | Neutral |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Fuchs Charles S. President, R&D Aug 10, 2026 | AWARD | 1,300,000 sh |
Hambleton Julie Director Jun 26, 2026 | AWARD | 29,888 sh |
LIU JEAN I Director Jun 26, 2026 | AWARD | 29,888 sh |
Bristol James Arthur Director Jun 26, 2026 | AWARD | 29,888 sh |
Casdin Alexander W. Director Jun 26, 2026 | AWARD | 29,888 sh |
Multani Pratik S Director Jun 26, 2026 | AWARD | 29,888 sh |
Start Valerie Denise Harding Director Jun 26, 2026 | AWARD | 29,888 sh |
Garner Ebun Chief Legal Officer Apr 1, 2026 | EXERCISE | $136.0K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.15 | -$0.19–-$0.12 | -15.1% | $0.00 |
| Next Q | -$0.14 | -$0.17–-$0.08 | -9.1% | $0.00 |
| Current FY | -$1.02 | -$1.05–-$0.99 | -4.5% | $0.00 |
| Next FY | -$0.75 | -$1.15–-$0.47 | -20.1% | $0.00 |
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 6 press releases · 5 bullish · 0 bearish · 4 mixed · 11 neutral- NEUTRAL 144Nov 16, 2026
Erasca Foundation, an affiliate holder, filed a Form 144 notice of intent to sell 8,333 shares of Erasca, Inc. common stock, with an estimated aggregate market value of approximately $129,256 based on a recent sale price of ~$15.51/share. The shares were originally acquired via donation on July…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13G/ANov 16, 2026
T. Rowe Price Investment Management filed an amended Schedule 13G disclosing a 4.9% passive stake in Erasca, representing 17,212,014 shares as of September 30, 2026. The stake is below the 5% threshold, indicating a reduction from a prior above-5% position.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13G/ANov 16, 2026
RTW Investments, LP filed an amended Schedule 13G disclosing a 6.4% passive stake in Erasca, Inc., representing 22,446,754 shares as of September 30, 2026. The filing is an amendment to a prior 13G and confirms the investor remains a passive holder with no change in control intent.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL PRESS-RELEASENov 12, 2026
Erasca reported a Q3 2026 net loss of $51.3M ($0.15/share), wider than the $30.6M loss a year ago…
Monitor upcoming ERAS-4001 Phase 1 data expected in H2 2026 and ERAS-0015 data in H1 2027 for signs of efficacy; the cash runway supports multiple registration-enabling trials through 2028, reducing…
All ERAS filing & press-release reports (26)
- 144 reportNov 16, 2026
- SC 13G/A reportNov 16, 2026
- SC 13G/A reportNov 16, 2026
- PRESS-RELEASE reportNov 12, 2026
- INST-CLUSTER reportNov 2, 2026
- 8-K reportOct 16, 2026
- 8-K reportAug 24, 2026
- 144 reportAug 17, 2026
- INST-CLUSTER reportAug 13, 2026
- 3 reportAug 12, 2026
- PRESS-RELEASE reportAug 11, 2026
- 8-K reportJul 14, 2026
- 424B5 reportJul 14, 2026
- PRESS-RELEASE reportJul 13, 2026
- PRESS-RELEASE reportJul 13, 2026
- INST-CLUSTER reportJun 12, 2026
- INST-CLUSTER reportJun 11, 2026
- INST-CLUSTER reportJun 11, 2026
- PRESS-RELEASE reportMay 11, 2026
- DEFA14A reportApr 28, 2026
- 8-K reportApr 27, 2026
- PRESS-RELEASE reportApr 27, 2026
- 8-K reportApr 27, 2026
- 8-K reportApr 21, 2026
- PRESS-RELEASE reportMar 12, 2026
- PRESS-RELEASE reportMar 5, 2026